Fred Alger Management’s Novavax NVAX Stock Holding History

Fred Alger Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-621,033	Closed	-$129M	–	542
2021 Q3	$129M	Buy	+621,033	New	+$137M	0.31%	102
2020 Q4	–	Sell	-10,524	Closed	-$1.14M	–	492
2020 Q3	$1.14M	Buy	+10,524	New	+$1.28M	﹤0.01%	333
2016 Q3	–	Sell	-4,260	Closed	-$619K	–	530
2016 Q2	$619K	Sell	4,260 -650	-13%	-$74.5K	﹤0.01%	362
2016 Q1	$507K	Sell	4,910 -31,535	-87%	-$3.38M	﹤0.01%	418
2015 Q4	$6.12M	Buy	36,445 +3,663	+11%	+$564K	0.03%	229
2015 Q3	$4.63M	Buy	32,782 +28,849	+734%	+$6.47M	0.03%	276
2015 Q2	$876K	Hold	3,933	–	–	﹤0.01%	432
2015 Q1	$650K	Buy	+3,933	New	+$639K	﹤0.01%	529

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Fred Alger Management's NVAX Position: Q4 2021 in Review

Fred Alger Management sold out of Novavax (NVAX) in Q4 2021, closing a stake of 621,033 shares — an estimated $129M sold.

Fred Alger Management first reported a position in NVAX in Q1 2015 and held it in 8 quarters. The position peaked at $129M in Q3 2021. 429 funds tracked by Wall St. Rank hold NVAX as of Q4 2021.

Fred Alger Management reported no remaining Novavax position as of Q4 2021 after selling out during the quarter.
Fred Alger Management sold 621,033 Novavax shares in Q4 2021, an estimated $129M.
Fred Alger Management first reported a position in Novavax in Q1 2015 and held it in 8 quarters.
Fred Alger Management's Novavax position peaked at $129M in Q3 2021.
429 funds tracked by Wall St. Rank held Novavax as of Q4 2021.

Based on Fred Alger Management's 13F filing for Q4 2021, filed 14 Feb 2022.